No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
APLT250117P2500
- 1.58
- +0.22+16.18%
15min DelayClose Dec 20 16:00 ET
1.60High1.58Low
1.60Open1.36Pre Close101 Volume4.70K Open Interest2.50Strike Price16.16KTurnover319.10%IV-4.55%PremiumJan 17, 2025Expiry Date1.62Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7951Delta0.3921Gamma0.53Leverage Ratio-0.0039Theta-0.0012Rho-0.42Eff Leverage0.0007Vega
Intraday
- 5D
- Daily
News
William Blair Downgrades Applied Therapeutics(APLT.US) to Hold Rating
William Blair Downgrades Applied Therapeutics (APLT) to a Hold
RBC Capital Maintains Applied Therapeutics(APLT.US) With Hold Rating, Cuts Target Price to $1.5
Applied Therapeutics Is Maintained at Sector Perform by RBC Capital
Applied Therapeutics Analyst Ratings
Applied Therapeutics CEO Shendelman Steps Down